Advertisement
Advertisement

NVS

NVS logo

Novartis AG

156.38
USD
Sponsored
+2.43
+1.58%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

156.62

+0.24
+0.16%

NVS Earnings Reports

Positive Surprise Ratio

NVS beat 25 of 40 last estimates.

63%

Next Report

Date of Next Report
Apr 27, 2026
Estimate for Q1 26 (Revenue/ EPS)
$14.00B
/
$2.27
Implied change from Q4 25 (Revenue/ EPS)
+4.96%
/
+12.38%
Implied change from Q1 25 (Revenue/ EPS)
+5.78%
/
--

Novartis AG earnings per share and revenue

On Feb 04, 2026, NVS reported earnings of 2.02 USD per share (EPS) for Q4 25, beating the estimate of 2.02 USD, resulting in a 0.27% surprise. Revenue reached 13.34 billion, compared to an expected 14.00 billion, with a -4.73% difference. The market reacted with a +2.04% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 2.27 USD, with revenue projected to reach 14.00 billion USD, implying an increase of 12.38% EPS, and increase of 4.96% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Eli Lilly & Co.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$6.73
Actual
$7.54
Surprise
+11.92%
logo
ABBVIE INC.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$2.70
Actual
$2.71
Surprise
+0.17%
logo
Merck & Co., Inc.
Report Date
Feb 03, 2026 For Q4 25
Estimate
$2.02
Actual
$2.04
Surprise
+0.52%
logo
Novo-Nordisk A/S
Report Date
Feb 04, 2026 For Q4 25
Estimate
$5.97
Actual
$6.32
Surprise
+5.77%
logo
Pfizer Inc.
Report Date
Feb 03, 2026 For Q4 25
Estimate
$0.57
Actual
$0.66
Surprise
+14.29%
logo
Sanofi - ADR
Report Date
Jan 29, 2026 For Q4 25
Estimate
$1.46
Actual
$1.53
Surprise
+4.22%
FAQ
For Q4 2025, Novartis AG reported EPS of $2.02, missing estimates by 0.27%, and revenue of $13.34B, -4.73% below expectations.
The stock price moved up 2.04%, changed from $149.86 before the earnings release to $152.91 the day after.
The next earning report is scheduled for Apr 27, 2026.
Based on 4 analysts, Novartis AG is expected to report EPS of $2.27 and revenue of $14.00B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement